Firivumab Biosimilar – Anti-hemagglutinin HA mAb – Research Grade

Reference:
Size

,

Brand

Product type

Clonality

Expression system

Description of Firivumab Biosimilar - Anti-hemagglutinin HA mAb - Research Grade

General information on Anti-Influenza A virus hemagglutinin HA[Influenza A virus] (Firivumab) Monoclonal Antibody

Firivumab has been investigated for the prevention and treatment of Influenza A infection.

Product nameFirivumab Biosimilar - Anti-hemagglutinin HA mAb - Research Grade
SourceCAS 1443004-15-6
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>95%
BufferPBS buffer PH7.5
Delivery conditionDry Ice
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsCT-P22
ReferencePX-TA1361
Related ProductsHemagglutinin(HA) Maryland
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody
SourceCAS 1443004-15-6

Reviews

There are no reviews yet.

Be the first to review “Firivumab Biosimilar – Anti-hemagglutinin HA mAb – Research Grade”

Your email address will not be published. Required fields are marked *


Clear
OK

Please select the country of delivery so that we can send you the quotation including shipping costs.

Thank you for your request! You will receive your quotation per e-mail in a few seconds.

If you did not receive your quotation, please check your spam folder.

Contact us to order

+33 (0)3 90 20 54 70

Write us

Categories: